Across TCGA pan-cancer cohorts, MIR3173 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR3173’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR3173 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR3173 is over-expressed in tumor, although a few such as STAD and THCA show the opposite, repressed pattern.
STAD and THCA are the cancer types where MIR3173 tumor–normal differential expression is most reproducible.